Abstract:Objective To investigate the serum lipid-specific serine protease inhibitor (Vaspin) levels and its relationship with insulin resistance in patients with polycystic ovary syndrome in order to explore its clinical significance. Methods From January 2016 to December 2018, 96 patients with PCOS were enrolled in the PCOS group and 96 patients with regular menstruation were enrolled in the control group (C group) in the Department of Obstetrics and Gynecology, Zhejiang Hospital. The age, body weight, waist-to-hip ratio (WHR), body mass index (BMI), fasting blood glucose (FPG), fasting insulin (FINS), glycosylated hemoglobin (HbA1c), triglyceride (TG) and total cholesterol (TC) were collected. The serum Vaspin levels were determined by enzyme-linked immunosorbent assay (ELISA). The steady-state model islet β-cell function index (HOMA-β) and the steady-state model insulin resistance index (HOMA-IR) were calculated. Results The body weight, WHR and BMI of the PCOS group were higher than those of the C group (P < 0.05). The Vaspin, FPG, FINS, HOMA-β, HOMA-IR and TG in the PCOS group were higher than those in the C group (P < 0.05). The serum Vaspin level in patients with PCOS was positively correlated with WHR (r = 0.418), BMI (r = 0.431), FINS (r = 0.387), HOMA-IR (r = 0.427) and TG (r = 0.512) (P < 0.05), and was not associated with body weight, FPG and HOMA-β (P > 0.05). Conclusion The serum Vaspin level is elevated in patients with polycystic ovary syndrome, and its level is positively correlated with insulin resistance.